| 摘要 |
2111335 9300330 PCTABS00019 The present invention relates to novel azanorbornane derivatives having formula (I), wherein R1 through R12 are as defined in the description, and to novel intermediates used in their synthesis. The compounds having formula (I) are useful in the treatment of inflammatory and central nervous system disorders, as well as other disorders.
|
